The rise is real — and it isn't one thing
If it feels like everyone you know is being diagnosed with ADHD, that's not your imagination. Diagnosis rates have climbed steadily for more than a decade, and adult diagnoses in particular have accelerated. The reasons stack on top of each other:
Awareness and reduced stigma. Twenty years ago, many adults with attention problems were told they were lazy, scattered, or "not living up to their potential." Today people have language for the experience. When a condition has a name, more people recognize themselves in it.
Adults are being diagnosed for the first time. The DSM-5 changed the required age of onset from "before age 7" to "before age 12," which captured a large group of adults who struggled in childhood but were never evaluated. Many people in their 30s, 40s, and 50s are only now getting an explanation for a lifetime of difficulty.
Women and the inattentive type were missed for decades. ADHD was long pictured as a disruptive boy who couldn't sit still. Girls with inattentive ADHD — quietly disorganized, forgetful, overwhelmed — were often labeled anxious, spacey, or simply "not trying hard enough." That generation is now seeking answers.
Telehealth widened the door. When care became available by video, people who couldn't take time off work, arrange childcare, or find a local provider suddenly could. That's a genuine win for access — and it also means more evaluations, more diagnoses, and, unfortunately, more shortcuts.
Social media accelerated self-referral. Short videos about ADHD symptoms reach millions of people and have done real good in reducing shame. They've also created a feedback loop where relatable content makes symptoms feel universal. Everyone occasionally loses their keys. That's not the same as a disorder that causes impairment across settings for years.
The pandemic raised the baseline of distraction. Remote work blurred boundaries, sleep schedules collapsed, and cognitive load went up. Many people noticed attention problems for the first time — some of which were ADHD all along, and some of which were burnout, anxiety, or grief.
Why the demand is specifically for stimulants
Here's the part that's harder to say plainly: stimulants are the most visible treatment for ADHD, and visibility drives demand.
They work quickly. A person can take a dose and notice a difference within an hour, which feels like proof. Therapy and behavioral strategies take weeks to show results by comparison. Quick feedback is powerful.
They also carry a cultural story about performance. In a work culture that treats productivity as a moral virtue, a medication that helps you focus can feel less like treatment and more like an advantage — especially for people who are struggling but not impaired in the clinical sense.
And the shortage amplified everything. When the FDA announced a stimulant shortage in 2022, it became national news. People who had never considered ADHD suddenly knew the word "Adderall." Pharmacies ran out, patients were rationed, and the topic stayed in the cultural conversation.
There's one more uncomfortable truth worth naming: stimulants improve focus in most people, whether or not they have ADHD. A medication that helps you concentrate is not evidence that you have a disorder of attention. That's precisely why the diagnosis has to rest on history, impairment, and pattern — not on how you feel after a trial dose.
What gets missed when the conversation starts with a prescription
When someone arrives already certain they need a specific medication, the most important part of the evaluation is the part they're least interested in: what else could this be?
Attention and concentration problems are among the most nonspecific symptoms in psychiatry. They show up in:
Here's why this matters: treating anxiety with a stimulant can make it worse. Treating unrecognized bipolar disorder with a stimulant can trigger mania. Missing sleep apnea means the real problem never gets treated. And for someone with a cardiovascular history, a stimulant is not a neutral choice.
Stimulants are effective and, for many people, genuinely life-changing. They also carry real risks: elevated blood pressure and heart rate, appetite loss, insomnia, anxiety, and — with misuse — dependence and diversion. None of that makes them bad medicine. It makes them medicine that deserves a real evaluation.
What a proper ADHD evaluation actually looks like
ADHD has no blood test, no scan, and no single questionnaire that can confirm it. The diagnosis is clinical, which means it's built from evidence assembled carefully:
The criteria. Symptoms of inattention and/or hyperactivity-impulsivity that have been present for at least six months, in a pattern inconsistent with developmental level.
Childhood onset. Clear evidence that several symptoms were present before age 12. This is where report cards, old school records, and a parent's memory become genuinely useful.
Two or more settings. Not just work, or just home. Symptoms have to show up across contexts.
Real impairment. Not "I'd like to focus better" — measurable consequences in work, school, relationships, finances, or driving.
The rule-out. A deliberate review of anxiety, depression, bipolar spectrum, trauma, sleep, medical causes, and substance use.
The structure. A comprehensive evaluation typically takes 60 to 90 minutes, sometimes across two visits, and includes standardized rating scales, a developmental and educational history, a collateral account from someone who knows you well, a medical and medication review, and a substance-use history. For some patients, it includes lab work, a sleep study referral, or coordination with a primary care provider.
At RayMex Wellness, ADHD evaluations are conducted by board-certified psychiatric providers — Nnemeka Okpala, PMHNP-BC, APRN, and Chinenye Udenna, PMHNP-BC — in person in Stoughton, MA, or by telehealth anywhere in Massachusetts and Rhode Island.
Treatment is not only stimulants
Stimulants get the headlines, but they're one option among several, and the right plan depends on the person.
Behavioral strategies — external structure, planners, reminders, environmental design, and coaching — build scaffolding that medication can't replace.
Therapy — cognitive behavioral therapy for ADHD has solid evidence for improving organization, time management, and emotional regulation.
Non-stimulant medications — atomoxetine, guanfacine, and viloxazine are effective for many people, particularly those with co-occurring anxiety, tics, or cardiovascular concerns, or a history of substance misuse.
Treating the sleep. Sometimes the most powerful intervention for attention is treating the apnea, the insomnia, or the shift work.
Lifestyle basics — sleep regularity, movement, and reducing chronic overload — are unglamorous and consistently underrated.
The goal isn't to avoid medication. It's to make sure that whatever you take is matched to what you actually have.
If you're wondering about yourself
That's a reasonable place to start — more reasonable than starting with a medication request. A few things help:
If the evaluation confirms ADHD, you'll have a diagnosis you can trust and a treatment plan built for you. If it doesn't, you'll have something more valuable: the actual explanation.
Next steps: learn about ADHD evaluation and treatment at RayMex Wellness, read what to expect at your first psychiatric appointment, check the insurance plans we accept, or explore telehealth psychiatry in Massachusetts and Rhode Island.
Frequently Asked Questions
Is ADHD overdiagnosed?
It's more accurate to say ADHD is unevenly diagnosed. Some people — especially women, adults, and people of color — were missed for decades and are only now being identified. Others are diagnosed from a short questionnaire without a real differential, which is where overdiagnosis happens. The quality of the evaluation matters more than the diagnosis rate.
Do stimulants help people who don't have ADHD?
Often, yes — they can improve focus and alertness in most people. That's exactly why feeling better on a stimulant isn't proof of ADHD. The diagnosis depends on developmental history, impairment across settings, and ruling out other causes.
Why is there a stimulant shortage?
Demand rose faster than manufacturers could scale production, and the DEA's production quotas limit how much can be made each year. Shortages have eased in some areas but remain inconsistent, which makes proper diagnosis and thoughtful prescribing more important, not less.
Can my primary care provider diagnose ADHD?
Many can, and for straightforward cases that's reasonable. Complex presentations — co-occurring anxiety, depression, trauma, bipolar concerns, cardiac history, or substance use — benefit from a psychiatric evaluation with someone who does this regularly.
